Compare SYK & DHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SYK | DHR |
|---|---|---|
| Founded | 1941 | 1969 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 141.2B | 162.7B |
| IPO Year | N/A | N/A |
| Metric | SYK | DHR |
|---|---|---|
| Price | $366.53 | $236.37 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 15 | 18 |
| Target Price | ★ $432.13 | $249.94 |
| AVG Volume (30 Days) | 1.7M | ★ 3.1M |
| Earning Date | 01-29-2026 | 01-28-2026 |
| Dividend Yield | ★ 0.96% | 0.54% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 7.61 | 4.87 |
| Revenue | ★ $24,381,000,000.00 | $24,268,000,000.00 |
| Revenue This Year | $11.98 | $3.76 |
| Revenue Next Year | $8.60 | $4.06 |
| P/E Ratio | ★ $48.14 | $48.61 |
| Revenue Growth | ★ 10.95 | 2.21 |
| 52 Week Low | $329.16 | $171.00 |
| 52 Week High | $406.19 | $258.23 |
| Indicator | SYK | DHR |
|---|---|---|
| Relative Strength Index (RSI) | 60.90 | 65.91 |
| Support Level | $344.63 | $227.23 |
| Resistance Level | $355.95 | $231.65 |
| Average True Range (ATR) | 5.54 | 3.84 |
| MACD | 0.94 | 0.47 |
| Stochastic Oscillator | 98.19 | 79.60 |
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life sciences and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.